Posts Tagged ‘Biotech’
INTERVIEW – Ana Pinto
🔺 Why Western Switzerland🇨🇭 is so attractive to life sciences companies? Ana Pinto, Business Partner at the Service de l’Économie du Canton de Neuchâtel has the answer.
Read MoreNagi Bioscience won a € 2,5 million grant from the EIC Accelerator
The company revolutionizes pre-clinical testing with its pioneer Organism-on-Chip technology Nagi Bioscience has been bestowed the prestigious and highly selective EIC Accelerator Grant supporting breakthrough innovation in Europe, funded by the Swiss State Secretariat for Education, Research and Innovation (SERI) for Swiss Startups, for its pioneer Organism-on-Chip technology. The EPFL spin-off uses C. elegans, a small worm…
Read MoreMedical devices for Ukraine
The Ukraine Embassy launches an appeal for donations Collection points in Switzerland The war in Ukraine has thrown millions of people into exile and the health situation there is dramatic. There is a shortage of medical devices needed for basic care, transport and treatment of the wounded, and intensive care. In this context, the…
Read MoreSEED Biosciences raises CHF 400 000
The EPFL spin-off has developed a pipetting robot that can dispense individual cells one by one. The device, called Dispencell, saves precious time – up to several weeks – for life science researchers, and accelerates research in the fields of pharmaceuticals, cancer or personalized medicine. Today, finding the perfect cure for every cancer patient…
Read MoreBioArk Monthey is expanding
A third building is under construction at BioArk Monthey Until now, BioArk has offered 6,000m2 of space between its first two buildings, BioArk I and II. BioArk III, with some 5,000m2 of floor space, including several 850m2 platforms, will house startups and companies active in the life sciences sector. The site offers unique multi-functional facilities,…
Read MoreCeidos revolutionises cell culture
The BioArk startup received a CHF 100 000 loan from FIT Advanced therapy medicinal products (ATMPs) are active medicines that are based on genes, tissues, or cells. They offer groundbreaking new opportunities for the treatment of cancers, degenerative diseases, genetic disorders, and injury. But producing them is a challenge and very expensive. Leonard Barras and…
Read MoreSuperlab Suisse Lausanne
A coworking space designed for scientists Located in the Biopôle in Lausanne, Superlab Suisse offers ready to move in laboratory spaces. Superlab Suisse’s «Lab as a Service» business concept includes innovatively designed laboratory facilities, state-of-the-art equipment, professional and concierge services, as well as financing support for companies in the biotech, pharma, and medtech sectors.…
Read MoreUNIGE: Fighting breast cancer cells growth
A low rate of a specific protein triggers tumors development. A UNIGE team found the counter-attack In about 2/3 of breast cancers, the hormone estrogen facilitates tumor growth. A tamoxifen-based treatment inhibits tumors’ estrogen receptors to prevent their development. But 40 % of treated patients develop a resistance to the molecule. The laboratory of…
Read More$11 million for EPFL spin-off Leman Biotech
A protein that boosts the immune system can cure 90% of cancer in mice Immunotherapy, which aims to boost the patient’s immune system to fight cancer, has no effect in two out of three cases. After a while, T lymphocytes, the main players against cancer cells, become exhausted. To give them a new lease…
Read MoreINTERVIEW : Massimo Nobile
🔺 Massimo Nobile, SwissBiotech Center CEO, explains how digital and life sciences are converging to create new medicines and treatments.
Read More